Concepedia

Guillermo Moreno‐Sanz

GM

Statistics

Publications

20

Citations

1.2K

H-Index

17

Active since

2008

Affiliations

University of California, Irvine(Current)

Italian Institute of Technology

University of Urbino

University of Parma

Universidad Complutense de Madrid

Guillermo Moreno‐Sanz is an author at University of California, Irvine specializing in pharmacology, medicine, and neuropharmacology.

ORCID

Publications per year

2008–2022

20

Publications

20

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

Jason R. Clapper, Guillermo Moreno‐Sanz, Roberto Russo et al. · Nature Neuroscience · 2010 · 342 citations · Full text

, , +14

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

Wei Don, Drake Dinh, DaYeon Lee et al. · Cannabis and Cannabinoid Research · 2016 · 120 citations · Full text

, , +15

Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models

Oscar Sasso, Guillermo Moreno‐Sanz, Cataldo Martucci et al. · Pain · 2012 · 105 citations · Full text

, , +16

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions

Oscar Sasso, Rosalia Bertorelli, Tiziano Bandiera et al. · Pharmacological Research · 2012 · 97 citations · Full text

, , +10

Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse

Zuzana Justinová, Leigh V. Panlilio, Guillermo Moreno‐Sanz et al. · Neuropsychopharmacology · 2015 · 88 citations · Full text

, , +16

1–5 of 20